Colworth Park
  • MIP Diagnostics Ltd. Signs Significant Commercial Agreement for Novel Security Applications

    MIP Diagnostics Ltd, the Molecularly Imprinted Polymers (MIPs) specialist based at Colworth Park, has today announced a collaborative agreement with commercial partners for the co-development and license of a novel MIP-based system with specific applications in the security field. The long-term benefits of the deal could have ground breaking implications in the target applications and […]

    Read More

  • Seasoned medical device company boss, Mark Harwood joins Camstent as CEO

    Camstent Ltd., the Colworth Park based company applying proprietary bacteria-phobic polymer coatings to medical devices, announces the appointment of Mark Harwood as CEO. Mark is a respected figure with an exceptional track record in the medical device sector. Mark is returning to the UK from Malaysia where he spent two and a half years undertaking […]

    Read More

  • Concepta raises £2.3m to help fund international launches of MyLotus

    Concepta PLC has conditionally raised £2.3m to help take its flagship myLotus fertility testing kit around the world. The AIM company recently launched the home-test kit, which allows women to identify their most fertile days, in the UK, where it can be found in Boots’ chemists, but bosses have moved to arm themselves with plenty […]

    Read More

  • Camstent Announce Positive Results For ‘Bacteria-Phobic’ Catheter

    Initial results from the first in-human pilot study could pave the way for a novel approach in the fight against super-bugs. Camstent, the Colworth based company applying proprietary bacteria-phobic polymer coatings to medical devices, has been notified of initial results from the first in-man pilot study for its CE marked coated catheter. The results, which […]

    Read More

  • Colworth Firm Strikes Walgreen Boots Alliance Deal

    Colworth Park based Concepta PLC has inked an agreement to supply its myLotus fertility testing kit to high street chemist Boots. The healthcare firm said the agreement with Walgreens Boots Alliance Inc, which owns both Boots and US pharmacy chain Walgreens, would allow it to supply Boots stores in the UK as well as other […]

    Read More

  • Camstent Raises £600K in Funding

    Camstent Ltd., a Colworth-based company developing proprietary bacteria-phobic polymers to apply to medical devices, raised £600k in funding. The company intends to use the funds to: – continue clinical evaluations, – pursue regulatory milestones, – make key appointments to the executive team, – double its manufacturing and lab space, – increase production of its unique […]

    Read More

  • Evolution Biotech to be awarded significant patent

    Evolution Biotechnologies (www.evolutionbiotech.com), the Colworth and US-based company pioneering the use of biological control to benefit human health, today reports the announcement by the European Patent Office of notification of intention to grant Evolution’s patent EP3331366, “Acaricides”. The patent protects Evolution’s lead technology, developing a biological control for the house dust mite as a preventative […]

    Read More

  • Concepta Diagnostic’s myLotus product gains CE-mark regulatory approval

    Colworth based Concepta plc, the innovative UK healthcare company and developer of the proprietary self-test platform (“myLotus”) and suite of emerging test products targeting the mobile health market is pleased to announce it has received CE-Mark certification for its myLotus branded products for women’s fertility. Given the stringent regulatory environment for diagnostics, CE certification is […]

    Read More

  • MIP Diagnostics : Imprinted Polymers and Sensors Seminar

    Join Colworth Park tenant MIP Diagnostics us at their inaugural MIP Seminar as they host a day of presentations, networking, and discussions with key opinion leaders in the field of imprinted polymers and sensors. The conference will bring together the international research communities as well as diagnostics experts from industry and academia, to discuss new […]

    Read More

  • Fiona Marshall to lead AgPlus Diagnostics

    AgPlus Diagnostics is delighted to announce the appointment of Fiona Marshall as CEO starting in January 2018. Fiona has worked for BBI Group since 2006 where she is currently the Managing Director of BBI Detection and was formerly the MD of BBI Solutions.   Christopher Getley, Chairman, said ‘Fiona’s strong record of both operational and commercial […]

    Read More